Lumito (LUMITO) Stock Overview
Engages in the medical research and development of imaging technology in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
LUMITO Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Lumito AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.042 |
| 52 Week High | SEK 0 |
| 52 Week Low | SEK 0 |
| Beta | 0.76 |
| 1 Month Change | -50.00% |
| 3 Month Change | -91.23% |
| 1 Year Change | -91.10% |
| 3 Year Change | -96.38% |
| 5 Year Change | -98.89% |
| Change since IPO | -97.94% |
Recent News & Updates
Health Check: How Prudently Does Lumito (NGM:LUMITO) Use Debt?
Jan 08
Lumito (NGM:LUMITO) Has Debt But No Earnings; Should You Worry?
Sep 18Recent updates
Health Check: How Prudently Does Lumito (NGM:LUMITO) Use Debt?
Jan 08Lumito (NGM:LUMITO) Has Debt But No Earnings; Should You Worry?
Sep 18Will Lumito (NGM:LUMITO) Spend Its Cash Wisely?
Jan 02We're Keeping An Eye On Lumito's (NGM:LUMITO) Cash Burn Rate
Sep 19Here's Why We're Not Too Worried About Lumito's (NGM:LUMITO) Cash Burn Situation
Jun 05We're Not Very Worried About Lumito's (NGM:LUMITO) Cash Burn Rate
Feb 13We Think Lumito (NGM:LUMITO) Needs To Drive Business Growth Carefully
Oct 31We're Keeping An Eye On Lumito's (NGM:LUMITO) Cash Burn Rate
Jul 17Will Lumito (NGM:LUMITO) Spend Its Cash Wisely?
Jun 07We're Not Very Worried About Lumito's (NGM:LUMITO) Cash Burn Rate
Feb 22Shareholder Returns
| LUMITO | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -2.3% | -1.8% | -0.7% |
| 1Y | -91.1% | -14.5% | 1.1% |
Return vs Industry: LUMITO underperformed the Swedish Medical Equipment industry which returned -13.5% over the past year.
Return vs Market: LUMITO underperformed the Swedish Market which returned 0.4% over the past year.
Price Volatility
| LUMITO volatility | |
|---|---|
| LUMITO Average Weekly Movement | 27.2% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in SE Market | 11.8% |
| 10% least volatile stocks in SE Market | 3.0% |
Stable Share Price: LUMITO's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: LUMITO's weekly volatility has increased from 18% to 27% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 8 | Sanna Wallenborg | lumito.se |
Lumito AB (publ) engages in the medical research and development of imaging technology in Sweden. It offers tissue analysis system based on upconverting nanoparticles, including SCIZYS system combining labeling and imaging technologies to locate and measure biomarkers in tissue samples. The company’s technology addresses challenges in various application areas, such as drug development, academic research, and clinical diagnostics.
Lumito AB (publ) Fundamentals Summary
| LUMITO fundamental statistics | |
|---|---|
| Market cap | SEK 11.70m |
| Earnings (TTM) | -SEK 49.40m |
| Revenue (TTM) | SEK 81.51k |
Is LUMITO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LUMITO income statement (TTM) | |
|---|---|
| Revenue | SEK 81.51k |
| Cost of Revenue | -SEK 873.89k |
| Gross Profit | SEK 955.40k |
| Other Expenses | SEK 50.35m |
| Earnings | -SEK 49.40m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.19 |
| Gross Margin | 1,172.18% |
| Net Profit Margin | -60,606.56% |
| Debt/Equity Ratio | 0% |
How did LUMITO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/10 00:44 |
| End of Day Share Price | 2025/11/10 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Lumito AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.